Alpana P Shukla

12PUBLICATIONS
12CO-AUTHORS
Aboriginal and Torres Strait Islander sport and physical activityCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Pharmaceutical delivery technologiesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 04, 2025
Improved health-related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT-5 trial.

Alpana P Shukla, Julia P Dunn, Elisa Gomez Valderas

|Feb 22, 2023
Five-year Weight Loss Maintenance With Obesity Pharmacotherapy.

Michael A Weintraub, Debra D'Angelo, Beverly G Tchang

|Oct 14, 2022
Medical weight management protects against weight gain during the COVID-19 pandemic.

Sarah R Barenbaum, Katherine H Saunders, Karina M Chan

|Oct 06, 2022
Tirzepatide: Does the Evidence to Date Show Potential for the Treatment of Early Stage Type 2 Diabetes?

Tanzila S Razzaki, Alyson Weiner, Alpana P Shukla

|Jun 06, 2022
Long-term weight loss maintenance with obesity pharmacotherapy: A retrospective cohort study.

Beverly G Tchang, Mohini Aras, Alan Wu

|Mar 11, 2021
The Independent Risk of Obesity and Diabetes and Their Interaction in COVID-19: A Retrospective Cohort Study.

Beverly G Tchang, Gulce Askin, Ageline Sahagun

Pageof 2